Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial

Table 3 Achievement of Secondary end point according to LN biopsy classes

Secondary end points achieved	CYC	MMF	p-value	Odds ratio	Confidence Interval
Secondary end points achieved	No. (%)	No.%	p-value	Odds ratio	Confidence Interval
Baseline biopsy Class III / III + V	3 (60%)	3 (42.9%)	1.000	0.50	0.048–5.152
Baseline biopsy class IV / IV + V	11 (68.8%)	11 (78.6%)	0.689	1.67	0.318–8.741

ISSN: 1471-2369